<table border="single" id="id_77584448-4f2f-4e96-a40d-b00c706838cc" width="411" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 14. Mean<linkhtml href="#footnote-1">*</linkhtml> Pharmacokinetic Parameters in Healthy Volunteers and Adult Patients With Epilepsy</caption>
<col span="1" width="21.5%"></col>
<col span="1" width="16.4%"></col>
<col span="1" width="20.9%"></col>
<col span="1" width="18.7%"></col>
<col span="1" width="22.5%"></col>
<tbody>
<tr>
<td>Adult Study Population</td>
<td>Number of Subjects</td>
<td>T<sub>max</sub>: Time of Maximum Plasma Concentration (hr)</td>
<td>t<sub>½</sub>: Elimination Half-life (hr)</td>
<td>Cl/F: Apparent Plasma Clearance (mL/min/kg)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Healthy volunteers taking no other medications:</content>
</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Single-dose Lamotrigine</td>
<td>179</td>
<td>2.2 (0.25 to 12)</td>
<td>32.8 (14 to 103)</td>
<td>0.44 (0.12 to 1.1)</td>
</tr>
<tr>
<td>Multiple-dose Lamotrigine</td>
<td>36</td>
<td>1.7 (0.5 to 4)</td>
<td>25.4 (11.6 to 61.6)</td>
<td>0.58 (0.24 to 1.15)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Healthy volunteers taking valproate:</content>
</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Single-dose Lamotrigine</td>
<td>6</td>
<td>1.8 (1 to 4)</td>
<td>48.3 (31.5 to 88.6)</td>
<td>0.3 (0.14 to 0.42)</td>
</tr>
<tr>
<td>Multiple-dose Lamotrigine</td>
<td>18</td>
<td>1.9 (0.5 to 3.5)</td>
<td>70.3 (41.9 to 113.5)</td>
<td>0.18 (0.12 to 0.33)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Patients with epilepsy taking valproate only:</content>
</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Single-dose Lamotrigine</td>
<td>4</td>
<td>4.8 (1.8 to 8.4)</td>
<td>58.8 (30.5 to 88.8)</td>
<td>0.28 (0.16 to 0.4)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Patients with epilepsy taking carbamazepine, phenytoin, phenobarbital, or primidone<linkhtml href="#footnote-2">†</linkhtml> plus valproate:</content>
</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Single-dose Lamotrigine</td>
<td>25</td>
<td>3.8 (1 to 10)</td>
<td>27.2 (11.2 to 51.6)</td>
<td>0.53 (0.27 to 1.04)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Patients with epilepsy taking carbamazepine, phenytoin, phenobarbital, or primidone:<footnoteref idref="id-43c4b175-8b15-4f18-9cac-da327dab65a8"></footnoteref>
</content>
</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Single-dose Lamotrigine</td>
<td>24</td>
<td>2.3 (0.5 to 5)</td>
<td>14.4 (6.4 to 30.4)</td>
<td>1.1 (0.51 to 2.22)</td>
</tr>
<tr>
<td>Multiple-dose Lamotrigine</td>
<td>17</td>
<td>2 (0.75 to 5.93)</td>
<td>12.6 (7.5 to 23.1)</td>
<td>1.21 (0.66 to 1.82)</td>
</tr>
<tr>
<td>
<br/>
</td>
</tr>
</tbody>
</table>